Some overseas media reported that Apple is working with a number of research institutions in the United States to develop applications to collect and organize genetic data of users. These apps will provide some iPhone users with the opportunity to help them with genetic testing. Among them, many people will be the first to conduct genetic testing. These new applications will be based on Apple's ResearchKit. This data integration platform collects information from user devices and packages the information for medical research. Hospitals and other researchers can connect to the ResearchKit platform to quickly access a large number of research samples.
Apple's next step is to collect the user's genetic data. Researchers will save the data in ResearchKit's cloud computing platform, some of which will appear directly on the user's iPhone.
A source also said that Apple hopes to announce new genetic applications at the World Developers Conference (WWDC) in June this year. Apple has not responded to this news.
As the core technology of precision medicine , gene sequencing has gradually gained market attention. Not only overseas giants including Apple are accelerating the pace of genetic sequencing, but domestic authorities are also pushing for precise medical strategies.
Earlier media reports, a few days ago, the Ministry of Science and Technology held the country's first expert meeting on precision medicine strategy, the meeting revealed that China's precision medical plan will be launched in the second half of 2015 or next year. According to the plan, by 2030, China's precision medical care will invest 60 billion yuan, of which the central government will pay 20 billion yuan, and the enterprise and local finance will support 40 billion yuan.
Qin Huaijin, director of the Science and Technology Department of the National Health and Family Planning Commission, confirmed this news. "At present, the National Health and Family Planning Commission and the Ministry of Science and Technology are preparing for the precision medicine plan. After the improvement, they will report to the State Council and are expected to be included in the national "Ten Three majors of "three major projects in science and technology development."
Huatai Securities said that the innovation of precision medical care as a medical model is of great significance to improving the health of our nationals. The future investment is expected to increase, and the golden development period will be ushered in the development of genetic sequencing technology and national policies. Accurate treatment is the next emerging sunrise industry. It is recommended to actively focus on related investment opportunities such as gene sequencing, tumor diagnosis and personalized medicine. Corresponding to Daan Gene, Dean Diagnostics, Zixin Pharmaceutical, Qianshan Pharmaceutical, Xinyuan, North Lu Pharmaceutical, Hengrui Medicine and other stocks.
Pet Massager,Cat Massage,Dog Massage,Pet Groomer Tools
Shenzhen Jie Zhong Lian Investment Co., Ltd. , https://www.szmeizons.com